logo

BLUEJET vs DCAL: Stock Comparison

BLUE JET HEALTHCARE vs DISHMAN CARBO AMCISUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

BLUE JET HEALTHCARE is the larger company by market capitalisation. BLUE JET HEALTHCARE shows a lower P/E, a higher ROE and a higher dividend yield, while DISHMAN CARBO AMCIS shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BLUEJET leads 9; DCAL leads 2 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLUEJETDCAL

Valuation lens

What price are you paying?

Market CapContext only
₹9,221 Cr
₹2,195 Cr
P/E RatioBLUEJET has the lower reading
35.98x ✓
135.92x
P/B RatioDCAL has the lower reading
6.21x
0.33x ✓
EPSBLUEJET has the higher reading
₹4.51 ✓
₹-3.69
Book ValueContext only
₹78.4
₹425.87
Dividend YieldBLUEJET has the higher reading
0.24% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BLUEJET is the larger company
₹9,221 Cr vs ₹2,195 Cr
P/E Ratio
BLUEJET has a lower P/E
35.98x vs 135.92x
P/B Ratio
DCAL has a lower P/B
0.33x vs 6.21x
EPS
BLUEJET has higher earnings per share
₹4.51 vs ₹-3.69
Dividend Yield
BLUEJET has a higher dividend yield
0.24% vs 0%
Revenue Growth (TTM YoY)
DCAL has faster revenue growth
18.9% vs -31.1%
EPS Growth (TTM YoY)
BLUEJET has faster EPS growth
-41.5% vs -49.5%
ROE
BLUEJET has a higher ROE
18.22% vs -0.99%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLUEJETDCAL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLUEJETDCAL
Live Price₹487.7₹140.02
Day Change-1.55%-1.46%
Volume2.62 L1.95 L
52-Week High₹688.5₹303
52-Week Low₹325₹128.5
Distance from 52W High-29.16%-53.79%

Valuation

MetricBLUEJETDCAL
Market Cap₹9,221 Cr₹2,195 Cr
P/E Ratio35.98x135.92x
P/B Ratio6.21x0.33x
EPS₹4.51₹-3.69
Book Value₹78.4₹425.87
Dividend Yield0.24%0%

Growth

MetricBLUEJETDCAL
Revenue Growth (TTM YoY)-31.1%18.9%
EPS Growth (TTM YoY)-41.5%-49.5%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricBLUEJETDCAL
ROE18.22%-0.99%
ROCE19.25%0.61%
Net Margin27.25%2.51%
Operating Margin35.76%11.78%
Debt to Equity0x0.16x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricBLUEJETDCAL
Promoter Holding73.15%59.32%
FII Holding0.82%▲ 0.2 pp6.86%▼ 0.59 pp
DII Holding7.49%▼ 1.63 pp2.07%▲ 0.44 pp
Public Holding18.55%▲ 1.44 pp31.75%▲ 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLUE JET HEALTHCARE and DISHMAN CARBO AMCIS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.